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COVID-19 is has been an emerging healthcare challenge during the last 
months. Herein we explain two cases with spontaneous pneumomediastinum 
as an atypical manifestation of COVID-19 disease; these two patients had 
confirmed COVID-19, leading to spontaneous pneumodeiastimun as an 
atypical manifestation during the course of hospital stay, presenting by abrupt 
deterioration in O2 saturation and symptoms. Spontaneous 
pneumomediastinum should be considered as a potential reason for the disease 
exacerbation in patients without previous history of mechanical ventilation. 
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Severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2), originated in Wuhan, China, has 
spread all over the world. The usual clinical features of 
patients are dry cough, fever, diarrhea, vomiting, and 
myalgia (1, 2). Nevertheless, COVID-19 does not 
necessarily present in a similar pattern, and a long list 
of atypical presentations and complications have been 
described (3, 4). This wide range of presentations could 
not be limited just to clinical signs; instead, the 
diagnostic patterns demonstrate many diagnostic 
diversities (1, 3). Many clinical studies have 
determined the most common expected radiological 
features of COVID-19 patients: multifocal ground-
glass and/or consolidative opacities which are usually 
bilateral, peripheral, and basal in distribution. Though 
some reports are available, it seems that different 
radiologic patterns have not been mentioned enough, 
especially when considering the many organs systems 
potentially involved in COVID-19 (1, 4). Among the 
many unusual findings, some involve the pulmonary 
system; however, pneumomediastinum has rarely been 
reported (5-8). Herein we report two cases of 
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spontaneous pneumomediastinum associated with 





The First Patient: 
A 54-year-old nonsmoking man with a past medical 
history of hypertension and past surgical history of 
right kidney transplant was admitted to the emergency 
department of our hospital with seven days of dry 
cough, shortness of breath, nausea, vomiting, and 
decreased appetite. There were only bibasilar crackles 
at auscultation. The O2 sat was normal on room air.  
The first unenhanced chest CT scan after 
admission shows bilateral patchy ground-glass 
opacities and consolidations mainly peripherally 
dispersed in favor of COVID-19 (Figure 1-A). 
Complete blood count showed no elevated Leukocytes 
(5000 cells per μL) with 10% of lymphocytes. Other 
analyses revealed increased D-Dimer (1304 ng/ml); 
CRP and LDH elevation. The RT-PCR test was 
positive for COVID-19.  
Treatment with antibiotics (ceftriaxone and 
metronidazole), antiviral (remdesivir), and 
corticosteroid (methylprednisolone) were 
administered. 
On hospital day fourteen, the patient 
experienced pleuritic pain and a decrease in oxygen 
saturation (88%) with O2 at 4L/min through a nasal 
cannula. A low-grade fever of 37.5°C was detected. 
Blood pressure was 140/77 mmHg and pulse rate was 
95 per minute.  
At this time, his respiratory rate was 34. The rest 
of the physical exam was normal. Crepitus around his 
neck and chest area was not noted. No leukocytosis 
was found (W.B.C: 5000 cells/μL).  
The second CT scan was performed which 
showed a significant amount of pneumomediastinum 
with no cervico-mediastinal emphysema and 
pneumothorax (Figure 1-B). 
The third CT scan was performed 6 days later 
and revealed resolving pneumomediastinum with 
conservative management (Figure 1-C).  
 
 
The Second Patient: 
A 71-year-old man with a past medical history of 
hypothyroidism complained of 3 days of fever (37.7°C, 










Figure 1-A. the first unenhanced chest CT scan after 
admission with mainly peripheral bilateral patchy 
ground-glass opacities and consolidations 
Figure 1-B. the second unenhanced CT- scan with 
deteriorated consolidations in addition to 
pneumomediastinum. 
Figure 1-C. the third CT Scan shows bilateral 
progressing consolidations and resolving 
Pneumomediastinum. 
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denied using tobacco and alcohol. Physical 
examination showed wheezing sounds at auscultation. 
Oxygen saturation was normal (96% without 02). First 
Chest CT-scan demonstrates peripheral ground-glass 
opacities predominantly in lower lobes in both lungs in 
favor of COVID-19 (Figure 2-A). Laboratory tests 
demonstrated leukocytosis (14,800 cells per μL) with 
the presence of lymphopenia (8%) and elevated C-
reactive protein (4+). COVID-19 PCR analysis was 
positive. The treatment with ceftriaxone and 
levofloxacin was started. 
On the thirteenth day of the hospital stay, the 
patient stated discomfort while breathing at rest with 
minimal exertion. The oxygen saturation was low 
(87% without O2). No fever was detected. Blood 
pressure was 120/83 mmHg and pulse rate was 92 per 
minute. His respiratory rate was 38. The rest of the 
physical exam was normal. Crepitus around his neck 
and chest area was not noted. White blood counts were 
decreased and within the normal range (8900 cells/μL). 
On suspicion of pulmonary emboli and to rule 
out other causes a pulmonary CT angiography was 
done, which was negative for pulmonary emboli but 
revealed pneumomediastinum in addition to existing 
ground-glass opacities (Figure 2-B), with no 
pneumothorax and no evidence for tracheal or 
esophageal perforation. Follow up CT scan 5 days later 
showed a decrease in the amount of 
pneumomediastinum (Figure 2-C).  
For these patients, no intervention was required. 
We continued the same treatment and followed the 
clinical status and radiological findings. The 
respiratory status of both of them was maintained 
stably without increased oxygen requirements. 
Their respiratory status became better and the 
supplemental oxygen requirements decreased 
gradually. They were discharged from the hospital in 





Pneumomediastinum refers to a situation where air 
occupies some parts of the mediastinum. Many 
methods can be used to verify such a situation, such as 
a chest X-ray and CT scanning of the thorax. 
Nonetheless, severe central chest pain is considered the 
main symptom. Another major symptom is 
subcutaneous emphysema, which specifically affects 
the face, neck, and chest. Spontaneous 










Figure 2-A. the first Chest CT-scan demonstrates 
peripheral ground-glass opacities in both lungs 
Figure 2-B. the second Chest CT scan shows 
pneumomesitinum in addition to ground glass opacities 
Figure 2-C. Chest CT-scan demonstrates resolving 
pneumomediastinum and progressing opacities 
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commonly caused by various medical conditions such 
as infections, thoracic surgery/pericardial fluid 
drainage, traumas, respiratory disorders like asthma, 
and chronic lung disease, and positive pressure 
ventilation (4-6). Although most cases receive 
treatment conservatively, this situation should be 
carefully monitored to avoid life-threatening 
conditions. 
The new pandemic of COVID-19 is the new 
worldwide challenge of healthcare systems; 
particularly due to its wide and different range of 
clinical and Paraclinical features. In severe reported 
cases (1-3), pneumomediastinum was observed as an 
uncommon respiratory syndrome. Although the exact 
mechanism is not fully understood, this might be 
related to diffuse alveolar injury and rise in alveolar 
pressure leading to vulnerable alveoli and therefore 
ruptured alveoli. Some of these severe reported cases 
have been complicated by pneumothorax (3-5). 
Despite very rare reports of the coexistence of 
pneumopericardium, pneumomediastinum, and 
subcutaneous emphysema, these can be 
simultaneously appearing in young people with a 
history of blunt trauma or asthma (6-8). 
However, none of these risk factors were 
reported in the history of our patients. Therefore, the 
pneumomediastinum should be associated with 
COVID-19 pneumonia. Notably, sepsis evidence and 
signs such as subcutaneous emphysema were not found 




Although pneumomediastinum could be starting in a 
self-limiting manner, it requires careful investigation 
to avoid exacerbating conditions in COVID-19. 
Besides, spontaneous pneumomediastinum should be 
considered as a potential reason for the disease 





The authors would like to appreciate the cooperation of 
all the physicians, nurses, and all other health care 
personnel, Department of Anesthesiology and Intensive 
Care Unit, Modarres Hospital, Shahid Beheshti 
University of Medical Sciences, Tehran, Iran for their 
kindness and dedicated efforts. 
 
 
Conflicts of Interest  





1. Alamdari NM, Afaghi S, Rahimi FS, Tarki FE, Tavana S, Zali A, 
et al. Mortality Risk Factors among Hospitalized COVID-19 Patients 
in a Major Referral Center in Iran. Tohoku J Exp Med. 
2020;252(1):73-84. 
2. Bikdeli B, Talasaz AH, Rashidi F, Sharif-Kashani B, Farrokhpour 
M, Bakhshandeh H, et al. Intermediate versus standard-dose 
prophylactic anticoagulation and statin therapy versus placebo in 
critically-ill patients with COVID-19: Rationale and design of the 
Inspiration/Inspiration-S studies. Thromb Res. 2020;196:382-94. 
3. Alamdari NM, Rahimi FS, Afaghi S, Zarghi A, Qaderi S, Tarki FE, 
et al. The impact of metabolic syndrome on morbidity and mortality 
among intensive care unit admitted COVID-19 patients. Diabetes 
Metab Syndr. 2020;14(6):1979-86. 
4. Najar Nobari N, Montazer F, Seirafianpour F, Nikkhah F, Aryanian 
Z, Goodarzi A. Histopathologic Changes and Cellular Events of 
Organs Systems in COVID-19. J cell mol Anesth. 2020;6(1):81-8. 
5. Besharat S, Malekpour Alamdari N. COVID 19 in a traumatic 
thoracic aortic injury patient. J Cell Mol Anesth. 2020;5(3):197-201. 
6. Zhou C, Gao C, Xie Y, Xu M. COVID-19 with spontaneous 
pneumomediastinum. Lancet Infect Dis. 2020;20(4):510. 
7. Amri Maleh P, Ezoji K, Latifi K, Seyfi S. Spontaneous 
Pneumomediastinum Unrelated to Invasive Ventilation in a Patient 
with SARS-CoV-2 (COVID-19): A Case Report. J Cell Mol Anesth. 
2020;6(1):93-6. 
8. Mohammadi Tofigh A, Shojaei S, Zebarjadi Bagherpour J, 
Mirkheshti A, Tahmasebi H. Subcutaneous Emphysema as an 
Ominous Side Effect in COVID-19 Patients under Mechanical 
Ventilation, Report of 7 Cases. J Cell Mol Anesth. 2020;5(3):202-5. 
 
